Vertex Pharmaceuticals, Inc. [VRTX] Revenue clocked in at $9.84 billion, up 2.27% YTD: What’s Next?
Vertex Pharmaceuticals, Inc. [NASDAQ: VRTX] closed the trading session at $416.13. The company report on February 5, 2024 at 4:06 PM that Vertex Reports Fourth Quarter and Full Year 2023 Financial Results. — Full year product revenue of $9.87 billion, an 11% increase compared to